94 related articles for article (PubMed ID: 16488400)
1. Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin.
Sonoda H; Ohta H; Watanabe K; Yamashita H; Kimura H; Sato Y
Biochem Biophys Res Commun; 2006 Apr; 342(2):640-6. PubMed ID: 16488400
[TBL] [Abstract][Full Text] [Related]
2. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells.
Sato Y; Sonoda H
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):37-41. PubMed ID: 17095714
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin.
Shibuya T; Watanabe K; Yamashita H; Shimizu K; Miyashita H; Abe M; Moriya T; Ohta H; Sonoda H; Shimosegawa T; Tabayashi K; Sato Y
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1051-7. PubMed ID: 16528006
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion.
Suzuki Y; Kobayashi M; Miyashita H; Ohta H; Sonoda H; Sato Y
J Cell Sci; 2010 Sep; 123(Pt 18):3094-101. PubMed ID: 20736312
[TBL] [Abstract][Full Text] [Related]
6. Expression pattern of Vasohibin during chick development.
Nimmagadda S; Geetha-Loganathan P; Pröls F; Scaal M; Christ B; Huang R
Dev Dyn; 2007 May; 236(5):1358-62. PubMed ID: 17394205
[TBL] [Abstract][Full Text] [Related]
7. Vasohibin prevents arterial neointimal formation through angiogenesis inhibition.
Yamashita H; Abe M; Watanabe K; Shimizu K; Moriya T; Sato A; Satomi S; Ohta H; Sonoda H; Sato Y
Biochem Biophys Res Commun; 2006 Jul; 345(3):919-25. PubMed ID: 16707096
[TBL] [Abstract][Full Text] [Related]
8. Processing in the C-terminal domain of minicollagen XII removes a heparin-binding site.
Aubert-Foucher E; Goldschmidt D; Jaquinod M; Mazzorana M
Biochem Biophys Res Commun; 2001 Sep; 286(5):1131-9. PubMed ID: 11527417
[TBL] [Abstract][Full Text] [Related]
9. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes.
Wakusawa R; Abe T; Sato H; Yoshida M; Kunikata H; Sato Y; Nishida K
Am J Ophthalmol; 2008 Aug; 146(2):235-243. PubMed ID: 18486097
[TBL] [Abstract][Full Text] [Related]
10. Is vasohibin-1 for more than angiogenesis inhibition?
Sato Y
J Biochem; 2011 Mar; 149(3):229-30. PubMed ID: 21217147
[TBL] [Abstract][Full Text] [Related]
11. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
12. Cleavage-site mutagenesis alters post-translation processing of Pro-CCK in AtT-20 cells.
Pratt JS; Blum A; Vishnuvardhan D; Kitagawa K; Beinfeld MC
Biochemistry; 2004 Jul; 43(29):9502-11. PubMed ID: 15260493
[TBL] [Abstract][Full Text] [Related]
13. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis.
Watanabe K; Hasegawa Y; Yamashita H; Shimizu K; Ding Y; Abe M; Ohta H; Imagawa K; Hojo K; Maki H; Sonoda H; Sato Y
J Clin Invest; 2004 Oct; 114(7):898-907. PubMed ID: 15467828
[TBL] [Abstract][Full Text] [Related]
14. The vasohibin family: Novel regulators of angiogenesis.
Sato Y
Vascul Pharmacol; 2012; 56(5-6):262-6. PubMed ID: 22286022
[TBL] [Abstract][Full Text] [Related]
15. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
16. A double WAP domain (DWD)-containing protein with proteinase inhibitory activity in Chinese white shrimp, Fenneropenaeus chinensis.
Du ZQ; Ren Q; Zhao XF; Wang JX
Comp Biochem Physiol B Biochem Mol Biol; 2009 Oct; 154(2):203-10. PubMed ID: 19545640
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of rabbit polyclonal antibodies against Vasohibin-2 for determination of its intracellular localization.
Sun J; Tu M; Han B; Xue X; Zhang Y; Wei J; Chen J; Lu Z; An Y; Cai B; Lv N; Jiang K; Miao Y; Gao W
Int J Oncol; 2013 Jul; 43(1):255-61. PubMed ID: 23615928
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
19. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
20. Folding, activity and targeting of mutated human cathepsin D that cannot be processed into the double-chain form.
Follo C; Castino R; Nicotra G; Trincheri NF; Isidoro C
Int J Biochem Cell Biol; 2007; 39(3):638-49. PubMed ID: 17188016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]